SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-20-000622
Filing Date
2020-05-29
Accepted
2020-05-29 09:21:28
Documents
2
Group Members
TYBOURNE CAPITAL MANAGEMENT LTDTYBOURNE KESARI LTDVISWANATHAN KRISHNAN

Document Format Files

Seq Description Document Type Size
1 sch13g.htm SC 13G 98193
2 exhibit99-1.htm EX-99.1 7687
  Complete submission text file 0000929638-20-000622.txt   107838
Mailing Address 30/F, AIA CENTRAL 1 CONNAUGHT ROAD C HONG KONG K3 XXXXX
Business Address 30/F, AIA CENTRAL 1 CONNAUGHT ROAD C HONG KONG K3 XXXXX 852-3983-6869
TYBOURNE CAPITAL MANAGEMENT (HK) LTD (Filed by) CIK: 0001553936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Subject) CIK: 0001725160 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91478 | Film No.: 20924280
SIC: 2834 Pharmaceutical Preparations